Genetically engineered CD80-pMHC-harboring extracellular vesicles for antigen-specific CD4⁺ T-cell engagement

Area of Science:

• Immunology
• Cell Biology
• Biotechnology

Background:

• Identifying low-frequency antigen-specific CD4+ T cells is vital for disease immunomonitoring.
• Current enrichment methods for T cells often face experimental challenges and primarily focus on CD8+ T cells, with limited advancements for CD4+ T cells.

Purpose of the Study:

• To develop and validate a new technique for the stimulation and expansion of antigen-specific CD4+ T cells.
• To address the limitations of existing methods for CD4+ T cell enrichment and expansion.

Main Methods:

• Utilized antigen-presenting extracellular vesicles (EVs) derived from genetically modified HeLa cells.
• Engineered EVs to express CD80 and peptide-MHC-II complexes (pMHCs) to mimic professional antigen-presenting cells (APCs).
• Applied the EV-based method to stimulate and expand antigen-specific CD4+ T cells from human PBMCs.

Main Results:

• Demonstrated potent stimulatory capacity of engineered EVs in activating both immortalized and primary human CD4+ T cells.
• Successfully expanded low-frequency influenza-specific CD4+ T cells from healthy individuals.
• Validated the efficiency and streamlined nature of the developed methodology.

Conclusions:

• The developed EV-based methodology provides an efficient and streamlined approach for detecting and expanding antigen-specific CD4+ T cells.
• This technique serves as a valuable alternative to current antigen-specific T-cell expansion protocols.
• The findings contribute to advancing immunomonitoring strategies for various diseases.